In DN, tubular SA-β-Gal expression correlates with body mass index (BMI) and blood glucose, and tubular p16 is associated with BMI, LDL cholesterol and HbA1c (Verzola et al. 2008). The gene discussed is CDKN2A; the disease is liver dysplastic nodule.